Published in Drug Week, October 1st, 2004
NAVIGATOR (Nateglinide and Valsartan in IGT Outcomes Research trial) is a massive global effort involving about 790 investigators in 40 countries.
NAVIGATOR investigators S. Priori and colleagues from the University of Pavia, Italy, screened more than 39,000 subjects with CVD/risk factors for CVD, not known to be diabetic, with a single oral...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.